VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
24 hedge funds and large institutions have $63.9M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$621K | |
| 2 | +$600K | |
| 3 | +$512K | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$414K |
| 5 |
Goldman Sachs
New York
|
+$383K |
Top Sellers
| 1 | -$397K | |
| 2 | -$35.9K | |
| 3 | -$33K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$17K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9K |